Buscar
01/12/2025
Update 2025 of the Spanish COPD Guidelines (GesEPOC): Pharmacological Treatment of Stable COPD
Miravitlles, M, Calle, M, Molina, J, Almagro, P, Gomez, JT, Trigueros, JA, Sánchez-Angarita, E, Cosio, BG, Casanova, C, López-Campos, JL, Riesco, JA, Simonet, P, Rigau, D, Iskakova, A, Sanz, MP, Sobradillo, P, Alcázar-Navarrete, B, Garin, N, Soler-Cataluña, JJ. Update 2025 of the Spanish COPD Guidelines (GesEPOC): Pharmacological Treatment of Stable COPD. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(12)DOI:10.1016/j.arbres.2025.10.008. PMID:41198528. IF:9.200(Q1/1D).
01/12/2025
Aligning research funding and the production of useful evidence to reduce research waste
Meza, N, Madrid, E, Urrútia, G, Clarke, M. Aligning research funding and the production of useful evidence to reduce research waste. Bmj Evidence-Based Medicine. 2025; 30(6)DOI:10.1136/bmjebm-2025-114324. PMID:41326283. IF:7.600(Q1/1D).
01/12/2025
ADOLESBIO-HS: A Real-World Multicenter Case Series on the Effectiveness and Safety of Adalimumab in Adolescents with Moderate-to-Severe Hidradenitis Suppurativa
Grau-Pérez, M, Ciudad, C, Molina-Leyva, A, Martorell, A, Vilarrasa, E, Albert, I, Garcias-Ladaria, J, Melgosa, FJ, Rivera, R, Campos, M, Haselgruber, S, Ochando, G, Pascual, JC, García-Ruiz, R, Alfageme, F. ADOLESBIO-HS: A Real-World Multicenter Case Series on the Effectiveness and Safety of Adalimumab in Adolescents with Moderate-to-Severe Hidradenitis Suppurativa. DERMATOLOGY. 2025; 241(5-6)DOI:10.1159/000546647. PMID:40587963. IF:2.700(Q2/4D).
01/12/2025
REVIEW OF PATIENT DECISION AIDS FOR PSORIASIS
Ferrer, AL, Belinchón, I, Serra, MC, Clua, MG, Mate, AR, Suárez, BP, Alarcón, SS, de la Cueva, P. REVIEW OF PATIENT DECISION AIDS FOR PSORIASIS. VALUE IN HEALTH. 2025; 28(12)DOI:. PMID:. IF:6.000(Q1/1D).